Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 245

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer

Open access
Cejalvo, Juan M., Martínez de Dueñas, Eduardo, Galván, Patricia, García-Recio, Susana, Burgués Gasión, Octavio, Paré, Laia, Antolín, Silvia, Martinello, Rosella, Blancas, Isabel, Adamo, Barbara, Guerrero-Zotano, Ángel, Muñoz, Montserrat, Nucíforo, Paolo, Vidal, María, Pérez, Ramón M., Chacón López-Muniz, José I., Caballero, Rosalía, Peg, Vicente, Carrasco, Eva, Rojo, Federico, Perou, Charles M., Cortés, Javier, Adamo, Vincenzo, Albanell, Joan, Gomis, Roger R., Lluch, Ana, Prat, Aleix · 2017 · Cancer Research

Abstract

Biological changes that occur during metastatic progression of breast cancer are still incompletely characterized. In this study, we compared intrinsic molecular subtypes and gene expression in 123 paired primary and metastatic tissues from breast cancer patients. Intrinsic subtype was identified using a PAM50 classifier and χ2 tests determined the differences in variable distribution. The rate of subtype conversion was 0% in basal-like tumors, 23.1% in HER2-enriched (HER2-E) tumors, 30.0% in luminal B tumors, and 55.3% in luminal A tumors. In 40.2% of cases, luminal A tumors converted to luminal B tumors, whereas in 14.3% of cases luminal A and B tumors converted to HER2-E tumors. We identified 47 genes that were expressed differentially in metastatic versus primary disease. Metastatic tumors were enriched for proliferation-related and migration-related genes and diminished for luminal-related genes. Expression of proliferation-related genes were better at predicting overall survival in metastatic disease (OSmet) when analyzed in metastatic tissue rather than primary tissue. In contrast, a basal-like gene expression signature was better at predicting OSmet in primary disease compared with metastatic tissue. We observed correlations between time to tumor relapse and the magnitude of changes of proliferation, luminal B, or HER2-E signatures in metastatic versus primary disease. Although the intrinsic subtype was largely maintained during metastatic progression, luminal/HER2-negative tumors acquired a luminal B or HER2-E profile during metastatic progression, likely reflecting tumor evolution or acquisition of estrogen independence. Overall, our analysis revealed the value of stratifying gene expression by both cancer subtype and tissue type, providing clinicians more refined tools to evaluate prognosis and treatment. Cancer Res; 77(9); 2213–21. ©2017 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-16-2717

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 245

Metadata

Authors
Cejalvo, J. M., Martínez de Dueñas, E., Galván, P., García-Recio, S., Burgués Gasión, O., Paré, L., Antolín, S., Martinello, R., Blancas, I., Adamo, B., Guerrero-Zotano, Á., Muñoz, M., Nucíforo, P., Vidal, M., Pérez, R. M., Chacón López-Muniz, J. I., Caballero, R., Peg, V., Carrasco, E., Rojo, F., Perou, C. M., Cortés, J., Adamo, V., Albanell, J., Gomis, R. R., Lluch, A., & Prat, A.
Venue
Cancer Research
Published
2017-04-30
Volume
77
Issue
9
Pages
2213-2221
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2591810315
Cited by
245
References
7
FWCI
6.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-16-2717
The paper
Cejalvo, J. M., Martínez de Dueñas, E., Galván, P., García-Recio, S., Burgués Gasión, O., Paré, L., Antolín, S., Martinello, R., Blancas, I., Adamo, B., Guerrero-Zotano, Á., Muñoz, M., Nucíforo, P., Vidal, M., Pérez, R. M., Chacón López-Muniz, J. I., Caballero, R., Peg, V., Carrasco, E., . . . Prat, A. (2017). Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-16-2717

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.